Nasal Drug Delivery Technology Market Scope And Analysis

  • Report Code : TIPRE00003419
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

Analyse de la dynamique et de la portée du marché des technologies d'administration nasale de médicaments d'ici 2025-2031

Buy Now

Nasal Drug Delivery Technology Market Report Scope

Report Attribute Details
Market size in 2024 US$ XX million
Market Size by 2031 US$ XX Million
Global CAGR (2025 - 2031) 6.4%
Historical Data 2021-2023
Forecast period 2025-2031
Segments Covered By Systèmes
  • dose unitaire
  • bidose
  • multidose
By Conteneurs
  • conteneurs sous pression
  • conteneurs non sous pression
By Forme posologique
  • poudres nasales
  • gels nasaux
  • gouttes et liquides nasaux
  • spray nasal
  • autres
By Application thérapeutique
  • rhinite allergique et non allergique
  • congestion nasale
  • vaccinations
  • autres applications
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Novartis AG
  • Pfizer, Inc.
  • Merck and Co., Inc.
  • Glaxosmithkline PLC
  • Johnson and Johnson Services, Inc.
  • 3M
  • BD
  • Astrazeneca PLC
  • Aegis Therapeutics, LLC